We are a research-based specialty
biopharma company determined
to give people worldwide a longer
and better life

We are developing the first vaccine
in the world for protection against
diarrhoea caused by ETEC in both
travellers and endemic populations

We distribute a wide range of
specialty biopharma products with
focus on vaccines and immunoglobulins

Scandinavian Biopharma

Welcome to Scandinavian Biopharma,

We are an entrepreneurial company specialised in global vaccine development, manufacturing, registration and commercialization of biopharmaceutical products. Our team has previously successfully developed, manufactured, registered and globally l[...]
Read more


Scandinavian Biopharma

Scandinavian Biopharma enters into Agreement with USAMRAA to facilitate the development of the oral vaccine ETVAX® against travellers’ diarrhoea

25th of September 2020, Scandinavian Biopharma (SBH) entered into an Agreement with the United States Army Medical Research Acquisition Activity (USAMRAA) to support the production and development of the vaccine, with the long-term goal of p[...]
Read more


Scandinavian Biopharma

Scandinavian Biopharma continues to expand and welcomes Erika Söderström as Key Account Manager

Scandinavian Biopharma continues to expand and has recruiting Erika Söderström to the new position as Key Account Manager. Erika is a nurse by education and has for the past 20 years worked in different positions within the vaccine-, pharmaceu[...]
Read more